|
1. |
Bioengineers, health-care technology and bioethics |
|
Journal of Medical Engineering&Technology,
Volume 9,
Issue 2,
1985,
Page 55-60
SahaSubrata,
MisraSima,
SahaPamela,
Preview
|
PDF (743KB)
|
|
摘要:
Technology has created moral dilemmas in recent years creating an increased interest in the field of bioethics, which affects engineers in biomedicine, physicians, other health-care professionals, and society in general. For example devices like the kidney dialysis machine or Nuclear Magnetic Resonance (NMR) diagnostic scanner demonstrate state-of-the-art capabilities, yet they are very expensive. Therefore, standards of the past involving health care and allocation of resources are changing, and professionals must be aware of this change, as well as the responsibility for complete testing and review during the research and development process of medical devices. In this paper, we illustrate technological impact and stress the necessity of an understanding of ethics in order to deal effectively with product liability, conflicts of interests, and allocation of scarce resources. Hopefully, this will result in awareness and education in ethics and professional reponsibilities.This symposium is sponsored by ASTM (American Society for Testing and Materials) Committee F-4 on Medical and Surgical Materials and Devices, in co-operation with the Committee on Biomedical Engineering of the American Academy of Orthopaedic Surgeons. It will cover, by invited and submitted papers (deadlinefor c. 500-word abstracts is 1 April 1985), four areas.
ISSN:0309-1902
DOI:10.3109/03091908509028765
出版商:Taylor&Francis
年代:1985
数据来源: Taylor
|
2. |
Biomedical engineering programme of the European Community |
|
Journal of Medical Engineering&Technology,
Volume 9,
Issue 2,
1985,
Page 61-68
BenekenJan E. W.,
BrownB. H.,
SkupinskiW.,
Preview
|
PDF (685KB)
|
|
摘要:
The objective of this article is to inform readers of the European Community's programme of work on medical engineering research. An outline of the history of the European Community and its research programme is given. More specific information is then included on the current programme of work and, finally, an Appendix is given naming the national delegates to whom comments can be addressed and from whom further information can be obtained.
ISSN:0309-1902
DOI:10.3109/03091908509028766
出版商:Taylor&Francis
年代:1985
数据来源: Taylor
|
3. |
The role of balloon angioplasty in the management of coronary artery disease |
|
Journal of Medical Engineering&Technology,
Volume 9,
Issue 2,
1985,
Page 69-73
DymondDuncan S.,
Preview
|
PDF (1408KB)
|
|
摘要:
PTCA is a new technique for the treatment of certain patients with coronary artery disease. It involves dilatation of stenotic segments of artery using a balloon catheter, and is carried out in cardiac catheterization laboratories. If successful, the need for coronary bypass surgery may be removed, although some patients with initially successful PTCA will come to surgery eventually. Successful PTCA is associated with relief of angina, improved angiographic appearances and coronary perfusion. The primary success rate is between 65% and 80%, and the restenosis rate approximately 25%. 80% of patients will be angina free one year after PTCA. In this paper the indications, contraindications, technology, results and complications are discussed.
ISSN:0309-1902
DOI:10.3109/03091908509028767
出版商:Taylor&Francis
年代:1985
数据来源: Taylor
|
|